Suppression of early treatments and natural immunity

SHAME on the hospital systems that systematically denied patients (and their begging families) this FDA-approved, Nobel prize winning, wonder drug.

Dr. Sapan Desai, who supplied the data for two prominent and later retracted studies, is said to have a history of cutting corners and misrepresenting information in pursuit of his ambitions.

The Surgisphere Scandal - Based on an article by Catherine Offord in The Scientist Magazine, this seminar is a case study in research misconduct. This session will dissect the case of an obscure U.S. company with a hastily constructed website that drove international health policy and brought major clinical trials to a halt within the span of a few weeks. The case centers on a paper published in The Lancet that suggested hydroxychloroquine, an antimalarial drug, was associated with an increased risk of death in patients hospitalized with COVID-19.

“It’s like the guy went crazy with Photoshop,” said one expert in scientific image manipulation.

If you search for scientific research articles with COVID-19 in the title, you’ll see more than 17,000 articles published since the start of 2020[i], but this vital research is being undermined by

Exclusive: Australian researchers query origin of data used for Lancet study, but stress there is no evidence drug is a safe or effective treatment

Malaria drug taken by Trump could raise risk of death and heart problems, study shows

Studies under microscope after Guardian investigation reveals flaws with data from US company Surgisphere

A vast database from a little-known company called Surgisphere has influenced rapid policy shifts as the world seeks treatments for Covid-19. But as researchers began to examine it more closely, they became increasingly concerned

Retractions by two of the world’s leading journals could do lasting harm in an environment where many already distrust scientists

Questions continue for Surgisphere and CEO Sapan Desai as universities deny knowledge of links to firm behind Lancet’s now-disputed blockbuster study

New England Journal of Medicine and Lancet peer reviewers did not see raw data behind findings before publication

Surgisphere issues public statement defending integrity of coronavirus study published in the Lancet

After publication of our Lancet Article,1 several concerns were raised with respect to the veracity of the data and analyses conducted by Surgisphere Corporation and its founder and our co-author, Sapan Desai, in our publication. We launched an independent third-party peer review of Surgisphere with the consent of Sapan Desai to evaluate the origination of the database elements, to confirm the completeness of the database, and to replicate the analyses presented in the paper.

The Canadian government severely restricted access to ivermectin by its citizens. Dr. Hoffe thus felt it appropriate for Canadians to obtain veterinary sources of ivermectin. I defend that view.

Waning of protection against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) conferred by 2 doses of the BNT162b2 vaccine begins shortly after inoculation and becomes substantial within 4 months. With that, the impact of prior ...

Original Article from The New England Journal of Medicine — Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2

This follow-up chart is a list of scientific studies and evidence on natural immunity to allow you to draw your own conclusions..

One hopes that the World Health Organization in the future will stick to science rather than allow its once-vaunted reputation to be manipulated

In the UK, the ‘COVID Therapeutics Advisory Panel’ played a critical role in deciding which drugs would be rolled out in the fight against COVID. The panel, we were told, was tasked to “accelerate delivery of large scale trials for COVID-19 treatments”. CTAP were to

The virus must be killed in the nasal cavity at least twice a day after coming back home for prevention and up to every four hours during active treatment. This is very important with the Omicron variant, which multiplies 70 times faster than the prior strains of the virus. Early treatment using this approach is associated with a 71% improvement...

Covid Care Guidance Protocols for treatments of Covid-19 including ivermectin NOTICE: These protocols are solely for educational purposes regarding potentially beneficial therapies for COVID-19. Never disregard professional medical advice because of something you have read on our website and releases. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment […]

Dr. Robert Malone testifies at the Texas Senate Committee on Health & Human Services on June 27th, 2022. Dr. Robert Malone is an internationally recognized scientist/physician and the original invento

Peter A. McCullough, MD, MPH, Texas Senate Testimony, Health and Human Services Committee, "Lessons Learned on Pandemic Response" June 27,2022. Senator Lois Kolkhorst, Chair

COVID

A recent study by Abu-Raddad et al., published in the formerly respectable New England Journal of Medicine, shows that acquired immunity against COVID works very much as it does with other respiratory viruses: it affords relative protection against reinfection and robust protection against severe disease or death.